Travere Therapeutics, Inc. - Common Stock (TVTX)

CUSIP: 89422G107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
92,326,601
Total 13F shares
52,293,956
Share change
+52,060,068
Total reported value
$1,423,328,983
Put/Call ratio
107%
Price per share
$27.26
Number of holders
135
Value change
+$1,416,953,984
Number of buys
131

Quarterly Holders Quick Answers

What is CUSIP 89422G107?
CUSIP 89422G107 identifies TVTX - Travere Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Travere Therapeutics, Inc. - Common Stock (TVTX) as of Q4 2020

As of 31 Dec 2020, Travere Therapeutics, Inc. - Common Stock (TVTX) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,293,956 shares. The largest 10 holders included BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MACQUARIE GROUP LTD, BANK OF AMERICA CORP /DE/, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and RENAISSANCE TECHNOLOGIES LLC. This page lists 135 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q4 2025 Across Filers

Q4 2025 holders
274
Q4 2020 holders
135
Holder diff
-139
Investor Q4 2025 Shares Q4 2020 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .